OBJECTIVE: To characterize a drug-combination nanoparticle (DcNP) containing water-insoluble lopinavir (LPV) and efavirenz (EFV), and water-soluble tenofovir (TFV), for its potential as a long-acting combination HIV treatment. DESIGN: Three HIV drugs (LPV, EFV, TFV) with well established efficacy and safety were coformulated into a single DcNP suspension. Two macaques were administered one subcutaneous injection and drug concentrations in plasma and mononuclear cells (in peripheral blood and lymph nodes) were analyzed over 2 weeks. Pharmacokinetic parameters and cell-to-plasma relationships of LPV, EFV, and TFV were determined. RESULTS: This three-in-one nanoformulation provided extended concentrations of all drugs in lymph node cells that were 57- to 228-fold higher than those in plasma. Levels of all three drugs in peripheral blood mononuclear cells persisted for 2 weeks at levels equal to or higher than those in plasma. CONCLUSION: With long-acting characteristics and higher drug penetration/persistence in cells, this three-in-one DcNP may enhance therapeutic efficacy of these well studied HIV drugs due to colocalization and targeting of this three-drug combination to HIV host cells.
OBJECTIVE: To characterize a drug-combination nanoparticle (DcNP) containing water-insoluble lopinavir (LPV) and efavirenz (EFV), and water-soluble tenofovir (TFV), for its potential as a long-acting combination HIV treatment. DESIGN: Three HIV drugs (LPV, EFV, TFV) with well established efficacy and safety were coformulated into a single DcNP suspension. Two macaques were administered one subcutaneous injection and drug concentrations in plasma and mononuclear cells (in peripheral blood and lymph nodes) were analyzed over 2 weeks. Pharmacokinetic parameters and cell-to-plasma relationships of LPV, EFV, and TFV were determined. RESULTS: This three-in-one nanoformulation provided extended concentrations of all drugs in lymph node cells that were 57- to 228-fold higher than those in plasma. Levels of all three drugs in peripheral blood mononuclear cells persisted for 2 weeks at levels equal to or higher than those in plasma. CONCLUSION: With long-acting characteristics and higher drug penetration/persistence in cells, this three-in-one DcNP may enhance therapeutic efficacy of these well studied HIV drugs due to colocalization and targeting of this three-drug combination to HIV host cells.
Authors: S Colombo; A Beguin; A Telenti; J Biollaz; T Buclin; B Rochat; L A Decosterd Journal: J Chromatogr B Analyt Technol Biomed Life Sci Date: 2005-05-25 Impact factor: 3.205
Authors: Courtney V Fletcher; Kathryn Staskus; Stephen W Wietgrefe; Meghan Rothenberger; Cavan Reilly; Jeffrey G Chipman; Greg J Beilman; Alexander Khoruts; Ann Thorkelson; Thomas E Schmidt; Jodi Anderson; Katherine Perkey; Mario Stevenson; Alan S Perelson; Daniel C Douek; Ashley T Haase; Timothy W Schacker Journal: Proc Natl Acad Sci U S A Date: 2014-01-27 Impact factor: 11.205
Authors: Jennifer P Freeling; Josefin Koehn; Cuiling Shu; Jianguo Sun; Rodney J Y Ho Journal: AIDS Res Hum Retroviruses Date: 2015-01 Impact factor: 2.205
Authors: S G Deeks; P Barditch-Crovo; P S Lietman; F Hwang; K C Cundy; J F Rooney; N S Hellmann; S Safrin; J O Kahn Journal: Antimicrob Agents Chemother Date: 1998-09 Impact factor: 5.191
Authors: Loren Kinman; Scott J Brodie; Che Chung Tsai; Tot Bui; Kay Larsen; Ann Schmidt; David Anderson; William R Morton; Shiu-Lok Hu; Rodney J Y Ho Journal: J Acquir Immune Defic Syndr Date: 2003-12-01 Impact factor: 3.731
Authors: Michele Di Mascio; Chang H Paik; Jorge A Carrasquillo; Jin-Soo Maeng; Beom-Su Jang; In Soo Shin; Sharat Srinivasula; Russ Byrum; Achilles Neria; William Kopp; Marta Catalfamo; Yoshiaki Nishimura; Keith Reimann; Malcolm Martin; H Clifford Lane Journal: Blood Date: 2009-05-05 Impact factor: 22.113
Authors: Heather Bradley; H Irene Hall; Richard J Wolitski; Michelle M Van Handel; Amy E Stone; Michael LaFlam; Jacek Skarbinski; Darrel H Higa; Joseph Prejean; Emma L Frazier; Roshni Patel; Ping Huang; Qian An; Ruiguang Song; Tian Tang; Linda A Valleroy Journal: MMWR Morb Mortal Wkly Rep Date: 2014-11-28 Impact factor: 17.586
Authors: Jesse Yu; Qingxin Mu; Simone Perazzolo; James I Griffin; Linxi Zhu; Lisa A McConnachie; Danny D Shen; Rodney Jy Ho Journal: Pharm Res Date: 2020-09-23 Impact factor: 4.200
Authors: Jane M Simoni; Kenneth Tapia; Sung-Jae Lee; Susan M Graham; Kristin Beima-Sofie; Zahra H Mohamed; Joan Christodoulou; Rodney Ho; Ann C Collier Journal: AIDS Behav Date: 2020-04
Authors: Qingxin Mu; Jesse Yu; James I Griffin; Yan Wu; Linxi Zhu; Lisa A McConnachie; Rodney J Y Ho Journal: PLoS One Date: 2020-03-06 Impact factor: 3.240